N

NanoViricides
D

NNVC

1.30500
USD
-0.03
(-1.88%)
Market Open
Volume
1,160
EPS
-0
Div Yield
-
P/E
-3
Market Cap
33,310,125
Overview
Related Instruments
A
ALT
D
Altimmune
2.32000
-0.11500(-4.72%)
2.41000+0.09000(+3.88%)
BNTX
BNTX
D
BioNTech SE American Depositary Share
89.130
0.190(0.21%)
89.150+0.020(+0.02%)
C
CODX
D
Co-Diagnostics Inc.
0.80720
-0.26280(-24.56%)
I
INO
D
Inovio Pharmaceuticals
0.96660
-0.02730(-2.75%)
1.02000+0.05340(+5.52%)
MRNA
MRNA
D
Moderna
224.795
8.625(3.99%)
216.970-7.825(-3.48%)
N
NVAX
D
Novavax
12.960
0.130(1.01%)
12.795-0.165(-1.27%)
More

Title: NanoViricides

Sector: Healthcare
Industry: Biotechnology
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.